Programmed cell death 1 ligand-1 (PD-L1, also known as CD274 and B7-H1), identified by Lieping Chen in 1999, represents one of the most important co-inhibitory molecules for cancer immunotherapy [16]. This evidence concerns the gene CD274 and cancer.